Press releases

In response to the commitments made at President Biden’s Second COVID-19 Summit today, especially the licensing of publicly owned medical technologies, such as the stabilized spike protein for use by the World Health Organization’s (WHO) COVID-19 Technology Access Pool (C-TAP) through the Medicines Patent Pool (MPP), Robbie Silverman, Oxfam America’s Senior Manager of Private Sector Advocacy, made the following statement:

World leaders have not done enough to achieve their goal of vaccinating 70% of people in each country by September, campaigners with the People’s Vaccine Alliance warned ahead of the second virtual summit on COVID-19 hosted by US President Biden along with Belize, Germany, Indonesia, and Senegal. The World Health Organization’s target of reaching 70% by mid-year is even further out of reach.

The COVID-19 pandemic has worsened the extreme inequality in Southern African Development Community (SADC) countries and pushed millions into poverty, reveals a new analysis from Oxfam, Norwegian Church Aid (NCA) and Development Finance International (DFI).

In reaction to the pledges made today at the Brussels conference on Syria, Oxfam in Syria Country Director, Moutaz Adham, said: “The pledges made today are welcomed and show that the international community has not forgotten Syrians."

The Greek government is operating “a two-tier refugee response” - one for Ukrainians and one for all other refugees according to a new briefing by the Greek Council for Refugees, Oxfam and Save the Children. 

In reaction to today’s "Global Report on Food Crises” which says that more than 193 million people across 53 countries are experiencing acute hunger and require urgent food, nutrition and livelihoods assistance, Oxfam Global Food Security and Livelihoods expert, Emily Farr, said: “It is deeply concerning to find extreme hunger increasing to a magnitude never seen before. 40 million more people have been pushed to extreme hunger, nearly a 25% surge since last year, and 80% since 2016."

Responding to the WTO’s published ‘outcome’ of negotiations over a waiver of Trade-Related aspects of Intellectual Property (TRIPS), Max Lawson, Head of Inequality Policy for Oxfam and co-chair of the People's Vaccine Alliance, said: "This text is a recognition that WTO rules on intellectual property are a clear barrier to ensuring people get the vaccines, tests, and treatments they need. It is a tragedy that it has taken almost two years and millions of deaths to reach this point and a travesty that the action proposed today falls well short of what is needed."

In response to this week’s UN General Assembly Resolution that automatically mandates the UN General Assembly to meet within 10 days in the wake of any UN Security Council veto, Oxfam’s Head of the UN New York Office, Brenda Mofya said,

An Oxfam resolution before Moderna shareholders received 24 percent of the nominal vote or 29 percent of the independent vote factoring in the 17 percent of the vote share owned by the company's directors and senior executives. A similar resolution before Pfizer shareholders garnered 27 percent of the vote.
 

In separate virtual addresses to the shareholders of Moderna, Pfizer, and Johnson & Johnson (JNJ), Oxfam called on the pharmaceutical corporations to improve COVID-19 vaccine equity and access so that everyone, everywhere has access to these life-saving shots.